We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Carlyle Group

News List

Piramal Pharma completes stake sale to Carlyle pharmaceutical-technology
October 10, 2020
Piramal Enterprises subsidiary Piramal Pharma has concluded the previously announced sale of its 20% stake to US-based global investment firm Carlyle Group in a deal valued approximately Rs35.234bn ($480m).
Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m pharmaceutical-business-review
July 01, 2020
US private equity firm Carlyle Group has agreed to acquire a stake of 20% stake in Piramal Pharma, the pharmaceutical business of Indian conglomerate Piramal Enterprises, in a deal worth up to $490m.
Carlyle Group to acquire 20 per cent stake in Piramal Pharma expresspharma
June 28, 2020
The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals.